46 results
425
CRVO
CervoMed Inc
3 Aug 23
Business combination disclosure
4:15pm
/information statement under the heading “Director Independence”:
Diffusion’s board of directors undertook a review of the independence of the proposed
8-K
CRVO
CervoMed Inc
3 Aug 23
Other Events
4:15pm
/information statement under the heading “Director Independence”:
Diffusion’s board of directors undertook a review of the independence of the proposed
8-K
EX-10.1
tmw25y3
16 Dec 22
Diffusion Pharmaceuticals Announces Agreement with LifeSci Special Opportunities
5:10pm
PRRN14A
ics64f 9wr
6 Dec 22
Revised preliminary proxy statement filed by non-management
8:30am
DEFC14A
ib6bid er4gvzn
5 Dec 22
Proxy in contested solicitation
5:12pm
PRRN14A
g0s6poho6m
2 Dec 22
Revised preliminary proxy statement filed by non-management
2:36pm
PRER14A
euyiqvqivodc5
28 Nov 22
Preliminary revised proxy
5:17pm
PREC14A
e8px0oe5 s1maex86
23 Nov 22
Preliminary proxy with contested solicitation
11:26am
PREC14A
v3ycyx18b 5cufl7a
18 Nov 22
Preliminary proxy with contested solicitation
5:08pm
8-K
EX-1.1
0bzvx3b
22 Jul 22
Entry into a Material Definitive Agreement
4:20pm
8-K
EX-1.1
a40m3
18 Feb 21
Diffusion Pharmaceuticals Announces $10 Million Bought Deal Offering of Common Stock
4:52pm